148 related articles for article (PubMed ID: 26745060)
1. FHIT Gene Expression in Acute Lymphoblastic Leukemia and its Clinical Significance.
Malak CA; Elghanam DM; Elbossaty WF
Asian Pac J Cancer Prev; 2015; 16(18):8197-201. PubMed ID: 26745060
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia.
Albitar M; Manshouri T; Gidel C; Croce C; Kornblau S; Pierce S; Kantarjian HM
Leuk Res; 2001 Oct; 25(10):859-64. PubMed ID: 11532518
[TBL] [Abstract][Full Text] [Related]
3. Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma.
Chen PM; Yang MH; Hsiao LT; Yu IT; Chu CJ; Chao TC; Yen CC; Wang WS; Chiou TJ; Liu JH
Oncol Rep; 2004 Feb; 11(2):349-56. PubMed ID: 14719066
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.
Stam RW; den Boer ML; Passier MM; Janka-Schaub GE; Sallan SE; Armstrong SA; Pieters R
Leukemia; 2006 Feb; 20(2):264-71. PubMed ID: 16357833
[TBL] [Abstract][Full Text] [Related]
5. Decreased or altered expression of the FHIT gene in human leukemias.
Sugimoto K; Yamada K; Miyagawa K; Hirai H; Oshimi K
Stem Cells; 1997; 15(3):223-8. PubMed ID: 9170214
[TBL] [Abstract][Full Text] [Related]
6. Loss of FHIT expression in acute lymphoblastic leukemia.
Hallas C; Albitar M; Letofsky J; Keating MJ; Huebner K; Croce CM
Clin Cancer Res; 1999 Sep; 5(9):2409-14. PubMed ID: 10499611
[TBL] [Abstract][Full Text] [Related]
7. Frequent aberration of FHIT gene expression in acute leukemias.
Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease (MRD) detection using rearrangement of immunoglobulin/T cell receptor genes in adult patients with acute lymphoblastic leukemia (ALL).
Shahkarami S; Mehrasa R; Younesian S; Yaghmaie M; Chahardouli B; Vaezi M; Rezaei N; Nikbakht M; Alimoghaddam K; Ghavamzadeh A; Tavakkoly-Bazzaz J; Ghaffari SH
Ann Hematol; 2018 Apr; 97(4):585-595. PubMed ID: 29392424
[TBL] [Abstract][Full Text] [Related]
9. Pattern of FHIT gene expression in normal and leukaemic cells.
Yang HW; Piao HY; Taki T; Chen T; Hashizume K; Ohnishi H; Bessho F; Yanagisawa M; Matsuo Y; Hayashi Y
Int J Cancer; 1999 Jun; 81(6):897-901. PubMed ID: 10362136
[TBL] [Abstract][Full Text] [Related]
10. Correlations of breast cancer FHIT gene with the incidence and prognosis of breast cancer.
Fu Y; Shan X; Song W; Xu K; Jiao C; Zhang Q
J BUON; 2019; 24(1):40-47. PubMed ID: 30941950
[TBL] [Abstract][Full Text] [Related]
11. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
12. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
[TBL] [Abstract][Full Text] [Related]
13. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic significance of livin/BIRC7 in childhood acute lymphoblastic leukemia.
Ibrahim L; Aladle D; Mansour A; Hammad A; Al Wakeel AA; Abd El-Hameed SA
Med Oncol; 2014 May; 31(5):941. PubMed ID: 24696218
[TBL] [Abstract][Full Text] [Related]
15. The significance of fragile histidine triad protein as a molecular prognostic marker of bladder urothelial carcinoma.
Zhang CT; Lu R; Lin YL; Liu RL; Zhang ZH; Yang K; Dang RF; Zhang HT; Shen YG; Kong PZ; Ren HL; Li XL; Quan W; Xu Y
J Int Med Res; 2012; 40(2):507-16. PubMed ID: 22613411
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PRAME gene in acute leukemia and its clinical significance].
Zhu YL; Liu J; Zhu P; DU JW; Zhang Y; Gu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1144-9. PubMed ID: 18088454
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression and deletion of FHIT gene in leukemias.
Wang L; Dong LJ; Tian F; Liu GX; Li CH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Apr; 11(2):153-60. PubMed ID: 12744737
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
19. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
20. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
Gao J; Yuan LX; Sun L; Li XX; Liao QK
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
